Glycosmedia - an international diabetes news service from the UK
  
 
Archived News
July 17th 2008
 
 
  Potential to Prevent Loss of Insulin in Type 2 Diabetes
  The compound, known as PBA, is already FDA approved for use in another clinical application. That suggests it could be fast tracked for use in humans to prevent or delay beta cell dysfunction (Garvan Institute, USA)
   
  Incretin-Based Therapies in Type 2 Diabetes Mellitus
  The availability of GLP-1 mimetics and DPP 4 inhibitors has increased our armamentarium for treating T2DM (Journal of Clinical Endocrinology & Metabolism)
   
  Diabetes Makes People More Vulnerable to TB: Study
  Diabetes makes a person about three times as likely to develop tuberculosis, and it may be to blame for more than 10 percent of TB cases in India and China, researchers said on Monday (ADA, USA)
   
 
  
© Copyright 2008 Glycosmedia Partnership